US Patent Issued to Tanabe Pharma on Jan. 27 for "Use of melanocortin-1 receptor agonist" (Japanese Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,350, issued on Jan. 27, was assigned to Tanabe Pharma Corp. (Osaka, Japan).

"Use of melanocortin-1 receptor agonist" was invented by Masahiro Kondo (Osaka, Japan), Tsuyoshi Suzuki (Osaka, Japan) and Yuko Kawano (Osaka, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "A medicament for treatment or prevention of interstitial lung disease, and of a disease or symptom accompanied by systemic sclerosis in a subject includes, as an effective ingredient, 1-{2-[(3S,4R)-1-{[(3R,4R)-1-cyclopentyl-3-fluoro-4-(4-methoxyphenyl)pyrrolidin-3-yl]carbonyl}-4-(methoxymethyl)pyrrolidin-3-yl]-5-(trifluoromethyl)phenyl}piperidine-4-carboxylic acid, or a pharmaceutic...